Market Cap 834.55M
Revenue (ttm) 0.00
Net Income (ttm) -74.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,301,100
Avg Vol 1,071,668
Day's Range N/A - N/A
Shares Out 90.81M
Stochastic %K 63%
Beta 0.04
Analysts Strong Sell
Price Target $14.00

Company Profile

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 206 4507
Address:
275 Shoreline Drive, Suite 500, Redwood City, United States
SweepCastApp
SweepCastApp Oct. 4 at 6:42 AM
$RZLT: Unusual Options Activity Alerted CALL flow observed 200x contracts at Strike price of $15 Exp on 01/16/2026 with Premium of $26K and showing BEARISH Sentiment
0 · Reply
Luhbonkers
Luhbonkers Oct. 2 at 7:27 PM
$GRRR up beautifully on $POET and $RZLT bonkers stay winning retard baggies from Taiwan named tzelka stay losing
1 · Reply
highnihilism
highnihilism Oct. 1 at 8:17 AM
$BIPC Brookfield Infrastructure Trade Count: 12 | Total $: 6.4 K | 1.27 × 90-Day Avg $: 5 K | Call $: 5.3 K | Put $: 1.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $JAMF Jamf Holding Trade Count: 21 | Total $: 6.5 K | 0.41 × 90-Day Avg $: 15.9 K | Call $: 5.3 K | Put $: 1.2 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PAR Par Technology Trade Count: 29 | Total $: 18.3 K | 0.71 × 90-Day Avg $: 25.9 K | Call $: 5.3 K | Put $: 13 K | % Single-Leg: 92% | % Multi-Leg: 8% | % Contingent: – $RZLT Rezolute Trade Count: 21 | Total $: 5.3 K | 0.14 × 90-Day Avg $: 38.6 K | Call $: 5.3 K | Put $: 45 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
oaksapollo
oaksapollo Oct. 1 at 2:40 AM
$RZLT I missed this when it was published in June, but the stock was $4 when this came out. I suspect publishing such a complete dataset for phase 2 in a solid, peer-reviewed journal has had a lot to do with the stock doubling in the last few months. https://www.sciencedirect.com/science/article/pii/S2666634025000388?via%3Dihub
0 · Reply
Cello69
Cello69 Sep. 30 at 7:31 PM
$RZLT Late day rip???
1 · Reply
Monty3030
Monty3030 Sep. 29 at 7:58 PM
$RZLT Will tomorrow be double digits?
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 5:35 PM
$RZLT Excellent article that nails exactly where RZLT stands right now. So if you want to update your RZLT knowledge or get acquainted with RZLT, this is a must read. https://beyondspx.com/quote/RZLT/analysis/rezolute-s-breakthrough-moment-ersodetug-poised-to-transform-hyperinsulinism-treatment-nasdaq-rzlt
0 · Reply
oaksapollo
oaksapollo Sep. 27 at 12:27 AM
$RZLT I think explains the run today https://slingshotinsights.com/projects/3976
0 · Reply
oaksapollo
oaksapollo Sep. 26 at 7:22 PM
$RZLT I wonder if there is some chance of an early read out here? Could they stop the trial early for efficacy? I didn’t think this was a possibility after the interim analysis earlier this year, but the stock is just running too much. Something is going on here, either an early read or buyout.
1 · Reply
Luhbonkers
Luhbonkers Sep. 26 at 3:37 PM
$RZLT 😉
0 · Reply
Latest News on RZLT
Rezolute to Participate in Upcoming Investor Conferences

Aug 27, 2025, 7:30 AM EDT - 5 weeks ago

Rezolute to Participate in Upcoming Investor Conferences


Rezolute: RZ402 Could Be A Surprise Candidate In The Making

May 1, 2025, 3:57 AM EDT - 5 months ago

Rezolute: RZ402 Could Be A Surprise Candidate In The Making


Rezolute, Inc. Announces Closing of Underwritten Offering

Apr 25, 2025, 4:30 PM EDT - 5 months ago

Rezolute, Inc. Announces Closing of Underwritten Offering


Rezolute: Late-Stage Study Targeting Hyperinsulinism

Feb 18, 2025, 1:30 AM EST - 8 months ago

Rezolute: Late-Stage Study Targeting Hyperinsulinism


Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day

Nov 17, 2023, 8:00 AM EST - 2 years ago

Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day


Rezolute Reports First Quarter Fiscal 2024 Results

Nov 13, 2023, 4:05 PM EST - 2 years ago

Rezolute Reports First Quarter Fiscal 2024 Results


SweepCastApp
SweepCastApp Oct. 4 at 6:42 AM
$RZLT: Unusual Options Activity Alerted CALL flow observed 200x contracts at Strike price of $15 Exp on 01/16/2026 with Premium of $26K and showing BEARISH Sentiment
0 · Reply
Luhbonkers
Luhbonkers Oct. 2 at 7:27 PM
$GRRR up beautifully on $POET and $RZLT bonkers stay winning retard baggies from Taiwan named tzelka stay losing
1 · Reply
highnihilism
highnihilism Oct. 1 at 8:17 AM
$BIPC Brookfield Infrastructure Trade Count: 12 | Total $: 6.4 K | 1.27 × 90-Day Avg $: 5 K | Call $: 5.3 K | Put $: 1.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $JAMF Jamf Holding Trade Count: 21 | Total $: 6.5 K | 0.41 × 90-Day Avg $: 15.9 K | Call $: 5.3 K | Put $: 1.2 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PAR Par Technology Trade Count: 29 | Total $: 18.3 K | 0.71 × 90-Day Avg $: 25.9 K | Call $: 5.3 K | Put $: 13 K | % Single-Leg: 92% | % Multi-Leg: 8% | % Contingent: – $RZLT Rezolute Trade Count: 21 | Total $: 5.3 K | 0.14 × 90-Day Avg $: 38.6 K | Call $: 5.3 K | Put $: 45 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
oaksapollo
oaksapollo Oct. 1 at 2:40 AM
$RZLT I missed this when it was published in June, but the stock was $4 when this came out. I suspect publishing such a complete dataset for phase 2 in a solid, peer-reviewed journal has had a lot to do with the stock doubling in the last few months. https://www.sciencedirect.com/science/article/pii/S2666634025000388?via%3Dihub
0 · Reply
Cello69
Cello69 Sep. 30 at 7:31 PM
$RZLT Late day rip???
1 · Reply
Monty3030
Monty3030 Sep. 29 at 7:58 PM
$RZLT Will tomorrow be double digits?
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 5:35 PM
$RZLT Excellent article that nails exactly where RZLT stands right now. So if you want to update your RZLT knowledge or get acquainted with RZLT, this is a must read. https://beyondspx.com/quote/RZLT/analysis/rezolute-s-breakthrough-moment-ersodetug-poised-to-transform-hyperinsulinism-treatment-nasdaq-rzlt
0 · Reply
oaksapollo
oaksapollo Sep. 27 at 12:27 AM
$RZLT I think explains the run today https://slingshotinsights.com/projects/3976
0 · Reply
oaksapollo
oaksapollo Sep. 26 at 7:22 PM
$RZLT I wonder if there is some chance of an early read out here? Could they stop the trial early for efficacy? I didn’t think this was a possibility after the interim analysis earlier this year, but the stock is just running too much. Something is going on here, either an early read or buyout.
1 · Reply
Luhbonkers
Luhbonkers Sep. 26 at 3:37 PM
$RZLT 😉
0 · Reply
Luhbonkers
Luhbonkers Sep. 25 at 4:41 AM
$RZLT this is going to 12 prior to the trial data. Expecting 18+ after.
1 · Reply
oaksapollo
oaksapollo Sep. 24 at 7:51 PM
$RZLT agree 100% with the first part. On 2nd part, it sure seems like it's happening before. The stock has doubled since July. I've never seen a run up to data that starts 6 months early and results in a 100% gain. Really feels like maybe they're in buyout talks and it leaked. That betaville guy should look into it!
0 · Reply
GollumSmeagol
GollumSmeagol Sep. 24 at 2:26 PM
$RZLT Looking like it is going to set a new 52 week high today, LFG!
0 · Reply
oaksapollo
oaksapollo Sep. 23 at 11:29 PM
$RZLT I sold November $15 covered calls today. Pretty friggin bullish that someone wanted to buy them.
1 · Reply
Luhbonkers
Luhbonkers Sep. 23 at 5:20 PM
$RZLT we all know
0 · Reply
Selfmademan
Selfmademan Sep. 22 at 5:30 PM
$RZLT i made a huge mistake with atyr. Live and learn. Never again will i invest without proper earlier phase 2 results. Hopefully Rezolute will correct that mistake in december. And if it does im planning already to reinvest profits to $CTMX
0 · Reply
IzzyOkm
IzzyOkm Sep. 22 at 3:51 PM
$RZLT another top today.
0 · Reply
JarvisFlow
JarvisFlow Sep. 22 at 12:47 PM
Guggenheim updates rating for Rezolute ( $RZLT ) to Buy, target set at 15.
0 · Reply
Monty3030
Monty3030 Sep. 19 at 8:04 PM
$RZLT Wow!! Over 4 million shares traded today! I smell something wonderful coming soon!
1 · Reply
anachartanalyst
anachartanalyst Sep. 19 at 7:02 PM
$RZLT https://anachart.com/wp-content/uploads/ana_temp/1758308533_soc-img.jpg
0 · Reply
fmcasado
fmcasado Sep. 19 at 1:44 PM
$RZLT buy and hold for a year!
0 · Reply
RunnerSignals
RunnerSignals Sep. 18 at 8:19 PM
Market Warriors Flip the Script $CRMD $EYE $RZLT $PLG $OGI turned early reds into greens today!
0 · Reply